NMDS Group logo

NMDS Group

News

The Nordic Collaborative Clinical Database Initiative and Allogeneic Stem Cell Transplantation Project for Myelodysplastic Syndromes has been granted funding for the year 2018 in the amount of 40000 EUR by the NCU Board of Directors.

Big grant of 100 million DKK has just been given from the Novo Nordisk Fonden to the Stem cell center Danstem, Copenhagen University, Denmark in order to establish a program especially designed for research for individual treatment of AML and MDS.

Congratulations to Professor and senior consultant Kirsten Grønbæk!

 

More information can be found here (in English): https://www.rigshospitalet.dk/english/news-and-media/news/Pages/2017/august/Researchers-to-look-for-new-therapies-for-blood-cancers-.aspx 

More information can be found here (in Danish): https://www.rigshospitalet.dk/presse-og-nyt/nyheder/nyheder/Sider/2017/august/Stor-donation-kan-bane-vejen-for-bedre-behandling-til-patienter-med-haematologisk-kraeft.aspx

 

 

 

SAVE THE DATES NOW!!
 
15th International Symposium on MDS, Copenhagen May 8-11
 
We are happy to announce that once again the Nordic MDS group will  host the Intenational MDS meeting in 2019. 
 
See you in Copenhagen!
 
Lars Kjeldsen and Kirsten Grønbæk. 

Title: Genotype-Phenotype Relations in SF3B1 Mutated Myelodysplastic Syndromes with Ring Sideroblasts

Author: Simona Conte, Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

Date: 2016-11-18

Location: Hörsalen, Novum, Blickagången 6, Karolinska University Hospital, Huddinge, Stockholm, Sweden

Time: 09:00

Supervisor: Professor Eva Hellström Lindberg, M.D., Ph.D., Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

Co-supervisors:
Docent Julian Walfridsson, Ph.D., Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Dr Liselotte Vesterlund, M.D., Ph.D., Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
 
Faculty opponent: Professor David P. Steensma, M.D. Harvard Medical School, Department of Medicine Division of Hematology/Oncology, Boston, MA, USA 
 
Contact person: This email address is being protected from spambots. You need JavaScript enabled to view it.